Advertisement

Plasmodium vivax Malaria in Latin America

  • Alfonso J. Rodriguez-MoralesEmail author
  • Adrián Bolívar-Mejía
  • Camila Alarcón-Olave
  • Lauren S. Calvo-Betancourt
Chapter
Part of the Neglected Tropical Diseases book series (NTD)

Abstract

Morbidity and mortality burden of malaria, particularly in children, represents a public health threat also in those countries from regions such as South East Asia and Latin America with moderate-to-low levels of transmission. Malaria mortality in these areas has been mainly attributed to P. falciparum, but its direct and indirect burden has not been well defined. These patterns are increasingly causing concern in some countries. Although P. falciparum is justifiably regarded as a greater menace because of its high mortality, widespread antimalarial drug resistance and its dominance in Africa, malaria due to P. vivax has also placed significant burdens on health, longevity and general prosperity of large sections of the human population. The debilitating impact of P. vivax malaria remains high, unacceptable and preventable for well over one billion inhabitants of the planet. Complicated and even fatal cases of malaria due to P. vivax have been increasingly reported in the medical literature. In Latin America, the burden of mortality due to malaria, although decreasing, is still significant. Powerful antimalarial campaigns in the region directed mainly to P. falciparum achieved a significant reduction of mortality in the last century. Evidence suggests that P. vivax can impose a significant burden of mortality that may have resulted from its interaction with other diseases and conditions, although this is largely neglected, compared to P. falciparum. These and other epidemiological issues are herein discussed, focusing in Latin America.

Keywords

Plasmodium vivax Plasmodium falciparum Latin America Caribbean Malaria Severe malaria 

References

  1. Acharya P, Pallavi R, Chandran S, Dandavate V, Sayeed SK, Rochani A, Acharya J, Middha S, Kochar S, Kochar D, Ghosh SK, Tatu U (2011) Clinical proteomics of the neglected human malarial parasite Plasmodium vivax. PLoS ONE 6(10):e26623. doi: 10.1371/journal.pone.0026623 PubMedCentralPubMedCrossRefGoogle Scholar
  2. Agudelo O, Arango E, Maestre A, Carmona-Fonseca J (2013) Prevalence of gestational, placental and congenital malaria in north-west Colombia. Malar J 12:341. doi: 10.1186/1475-2875-12-341 PubMedCentralPubMedCrossRefGoogle Scholar
  3. Alexandre MA, Ferreira CO, Siqueira AM, Magalhaes BL, Mourao MP, Lacerda MV, Alecrim M (2010) Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg Infect Dis 16(10):1611–1614. doi: 10.3201/eid1610.100685 PubMedCentralPubMedCrossRefGoogle Scholar
  4. Andrade BB, Reis-Filho A, Souza-Neto SM, Clarencio J, Camargo LM, Barral A, Barral-Netto M (2010) Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Malar J 9:13. doi: 10.1186/1475-2875-9-13 PubMedCentralPubMedCrossRefGoogle Scholar
  5. Anstey NM, Handojo T, Pain MC, Kenangalem E, Tjitra E, Price RN, Maguire GP (2007) Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J Infect Dis 195(4):589–596. doi: 10.1086/510756 PubMedCentralPubMedCrossRefGoogle Scholar
  6. Anstey NM, Douglas NM, Poespoprodjo JR, Price RN (2012) Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol 80:151–201. doi: 10.1016/B978-0-12-397900-1.00003-7 PubMedCrossRefGoogle Scholar
  7. Arboleda M, Perez MF, Fernandez D, Usuga LY, Meza M (2012) Clinical and laboratory profile of Plasmodium vivax malaria patients hospitalized in Apartado, Colombia. Biomedica: revista del Instituto Nacional de Salud 32(Suppl 1):58–67. doi: 10.1590/S0120-41572012000500008 Google Scholar
  8. Baird JK (2013) Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev 26(1):36–57. doi:10.1128/CMR. 00074-12PubMedCentralPubMedCrossRefGoogle Scholar
  9. Barrera R, Grillet ME, Rangel Y, Berti J, Ache A (1999) Temporal and spatial patterns of malaria reinfection in northeastern Venezuela. Am J Trop Med Hyg 61(5):784–790PubMedGoogle Scholar
  10. Berkley JA, Bejon P, Mwangi T, Gwer S, Maitland K, Williams TN, Mohammed S, Osier F, Kinyanjui S, Fegan G, Lowe BS, English M, Peshu N, Marsh K, Newton CR (2009) HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria. Clin Infect Dis 49(3):336–343. doi: 10.1086/600299 PubMedCentralPubMedCrossRefGoogle Scholar
  11. Campos IM, Uribe ML, Cuesta C, Franco-Gallego A, Carmona-Fonseca J, Maestre A (2011) Diagnosis of gestational, congenital, and placental malaria in Colombia: comparison of the efficacy of microscopy, nested polymerase chain reaction, and histopathology. Am J Trop Med Hyg 84(6):929–935. doi:10.4269/ajtmh. 2011.10-0507PubMedCentralPubMedCrossRefGoogle Scholar
  12. Carlton JM, Sina BJ, Adams JH (2011) Why is Plasmodium vivax a neglected tropical disease? PLoS Negl Trop Dis 5(6):e1160. doi: 10.1371/journal.pntd.0001160 PubMedCentralPubMedCrossRefGoogle Scholar
  13. Chaparro P, Padilla J, Vallejo AF, Herrera S (2013) Characterization of a malaria outbreak in Colombia in 2010. Malar J 12:330. doi: 10.1186/1475-2875-12-330 PubMedCentralPubMedCrossRefGoogle Scholar
  14. Chenet SM, Schneider KA, Villegas L, Escalante AA (2012) Local population structure of Plasmodium: impact on malaria control and elimination. Malar J 11:412. doi: 10.1186/1475-2875-11-412 PubMedCentralPubMedCrossRefGoogle Scholar
  15. Cifuentes SG, Trostle J, Trueba G, Milbrath M, Baldeon ME, Coloma J, Eisenberg JN (2013) Transition in the cause of fever from malaria to dengue, Northwestern Ecuador, 1990–2011. Emerg Infect Dis 19(10):1642–1645. doi: 10.3201/eid1910.130137 PubMedCentralPubMedCrossRefGoogle Scholar
  16. Costa FT, Lopes SC, Albrecht L, Ataide R, Siqueira AM, Souza RM, Russell B, Renia L, Marinho CR, Lacerda MV (2012) On the pathogenesis of Plasmodium vivax malaria: perspectives from the Brazilian field. Int J Parasitol 42(12):1099–1105. doi: 10.1016/j.ijpara.2012.08.007 PubMedCrossRefGoogle Scholar
  17. Cox-Singh J, Davis TM, Lee KS, Shamsul SS, Matusop A, Ratnam S, Rahman HA, Conway DJ, Singh B (2008) Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis 46(2):165–171. doi: 10.1086/524888 PubMedCentralPubMedCrossRefGoogle Scholar
  18. Curley JM, Mody RM, Gasser RA Jr (2011) Malaria caused by Plasmodium vivax complicated by acalculous cholecystitis. Am J Trop Med Hyg 85(1):42–49. doi:10.4269/ajtmh. 2011.10-0724PubMedCentralPubMedCrossRefGoogle Scholar
  19. de Lacerda MV, Zackiewicz C, Alecrim WD, Alecrim M (2007) The neglected Plasmodium vivax: are researchers from endemic areas really concerned about new treatment options? Rev Soc Bras Med Trop 40(4):489–490PubMedCrossRefGoogle Scholar
  20. Delgado-Petrocelli L, Cordova K, Camardiel A, Aguilar VH, Hernandez D, Ramos S (2012) Analysis of the El Nino/La Nina-Southern oscillation variability and malaria in the Estado Sucre, Venezuela. Geospat Health 6(3):S51–S57PubMedCrossRefGoogle Scholar
  21. Ferreira MU, Da Silva-Nunes M (2010) Evidence-based public health and prospects for malaria control in Brazil. J Infect Dev Ctries 4(9):533–545PubMedCrossRefGoogle Scholar
  22. Fitri LE, Sardjono TW, Hermansyah B, Candradikusuma D, Berens-Riha N (2013) Unusual presentation of vivax malaria with anaemia, thrombocytopenia, jaundice, renal disturbance, and melena: a report from malang, a nonendemic area in Indonesia. Case Rep Infect Dis 2013:686348. doi: 10.1155/2013/686348 PubMedCentralPubMedGoogle Scholar
  23. Flores-Torres J, Echeverria-Ortega M, Arria-Bohorquez M, Hidalgo G, Albano-Ramos C, Sanz R, Rodriguez-Morales AJ (2011) Differences between observed and estimated by hematocrit hemoglobin and its relevance in the diagnosis of anemia among coastal population in Venezuela: analysis of the second national study of human growth and development (SENACREDH). Rev Peru Med Exp Salud Publica 28(1):47–53PubMedCrossRefGoogle Scholar
  24. Franco-Paredes C, Jones D, Rodriguez-Morales AJ, Santos-Preciado JI (2007) Commentary: improving the health of neglected populations in Latin America. BMC Public Health 7:11. doi: 10.1186/1471-2458-7-11 PubMedCentralPubMedCrossRefGoogle Scholar
  25. Gabaldon A (1956) The time required to reach eradication in relation to malaria constitution. Am J Trop Med Hyg 5(6):966–976PubMedGoogle Scholar
  26. Gething PW, Elyazar IR, Moyes CL, Smith DL, Battle KE, Guerra CA, Patil AP, Tatem AJ, Howes RE, Myers MF, George DB, Horby P, Wertheim HF, Price RN, Mueller I, Baird JK, Hay SI (2012) A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis 6(9):e1814. doi: 10.1371/journal.pntd.0001814 PubMedCentralPubMedCrossRefGoogle Scholar
  27. Griffing SM, Villegas L, Udhayakumar V (2014) Malaria control and elimination, Venezuela, 1800s–1970s. Emerg Infect Dis 20(10):1697–1704PubMedCrossRefGoogle Scholar
  28. Grillet ME, El Souki M, Laguna F, Leon JR (2014) The periodicity of Plasmodium vivax and Plasmodium falciparum in Venezuela. Acta Trop 129:52–60. doi: 10.1016/j.actatropica.2013.10.007 PubMedCrossRefGoogle Scholar
  29. Gulati S (2012) Plasmodium vivax malaria: is it actually benign? J Infect Public Health 5(4):317. doi: 10.1016/j.jiph.2011.09.004 PubMedCrossRefGoogle Scholar
  30. Hiwat H, Hardjopawiro LS, Takken W, Villegas L (2012) Novel strategies lead to pre-elimination of malaria in previously high-risk areas in Suriname, South America. Malar J 11:10. doi: 10.1186/1475-2875-11-10 PubMedCentralPubMedCrossRefGoogle Scholar
  31. Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A (2005) Plasmodium vivax malaria. Emerg Infect Dis 11(1):132–134. doi: 10.3201/eid1101.040519 PubMedCentralPubMedCrossRefGoogle Scholar
  32. Kute VB, Goswami JG, Vanikar AV, Shah PR, Gumber MR, Patel HV, Kanodia KV, Trivedi HL (2012a) Unusual presentation of Plasmodium vivax: a neglected human malaria parasite. Parasitol Res 110(6):2573–2576. doi: 10.1007/s00436-011-2776-7 PubMedCrossRefGoogle Scholar
  33. Kute VB, Trivedi HL, Vanikar AV, Shah PR, Gumber MR, Patel HV, Goswami JG, Kanodia KV (2012b) Plasmodium vivax malaria-associated acute kidney injury, India, 2010–2011. Emerg Infect Dis 18(5):842–845. doi: 10.3201/eid1805.111442 PubMedCentralPubMedCrossRefGoogle Scholar
  34. Kute VB, Vanikar AV, Shah PR, Shrimali JD, Gumber MR, Patel HV, Modi PR, Trivedi HL (2013) Postrenal transplant Plasmodium vivax malaria: neglected and not benign. Parasitol Res 112(4):1791–1793. doi: 10.1007/s00436-012-3225-y PubMedCrossRefGoogle Scholar
  35. Lacerda MV, Alexandre MA, Santos PD, Arcanjo AR, Alecrim WD, Alecrim MG (2004) Idiopathic thrombocytopenic purpura due to vivax malaria in the Brazilian Amazon. Acta Trop 90(2):187–190. doi: 10.1016/j.actatropica.2003.12.001 PubMedCrossRefGoogle Scholar
  36. Lacerda MV, Mourao MP, Coelho HC, Santos JB (2011) Thrombocytopenia in malaria: who cares? Mem Inst Oswaldo Cruz 106(Suppl 1):52–63PubMedCrossRefGoogle Scholar
  37. Lacerda MV, Fragoso SC, Alecrim MG, Alexandre MA, Magalhaes BM, Siqueira AM, Ferreira LC, Araujo JR, Mourao MP, Ferrer M, Castillo P, Martin-Jaular L, Fernandez-Becerra C, del Portillo H, Ordi J, Alonso PL, Bassat Q (2012a) Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis 55(8):e67–e74. doi: 10.1093/cid/cis615 PubMedCrossRefGoogle Scholar
  38. Lacerda MV, Mourao MP, Alexandre MA, Siqueira AM, Magalhaes BM, Martinez-Espinosa FE, Filho FS, Brasil P, Ventura AM, Tada MS, Couto VS, Silva AR, Silva RS, Alecrim MG (2012b) Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Malar J 11:12. doi: 10.1186/1475-2875-11-12 PubMedCentralPubMedCrossRefGoogle Scholar
  39. Lee G, Yori P, Olortegui MP, Pan W, Caulfield L, Gilman RH, Sanders JW, Delgado HS, Kosek M (2012) Comparative effects of vivax malaria, fever and diarrhoea on child growth. Int J Epidemiol 41(2):531–539. doi: 10.1093/ije/dyr190 PubMedCentralPubMedCrossRefGoogle Scholar
  40. Mendis K, Sina BJ, Marchesini P, Carter R (2001) The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64(1–2 Suppl):97–106PubMedGoogle Scholar
  41. Metzger WG, Magris M, Vivas-Martinez S, Giron A, Brooms JD, Villalobos N, Cruz L, Pena Pimentel FN, Perez L, Espana R (2012) High dose artesunate in combination with mefloquine: pharmacovigilance in the Venezuelan Amazon. Trans R Soc Trop Med Hyg 106(3):196–198. doi: 10.1016/j.trstmh.2011.11.004 PubMedCrossRefGoogle Scholar
  42. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, del Portillo HA (2009) Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 9(9):555–566. doi: 10.1016/S1473-3099(09)70177-X PubMedCrossRefGoogle Scholar
  43. Oliveira-Ferreira J, Lacerda MV, Brasil P, Ladislau JL, Tauil PL, Daniel-Ribeiro CT (2010) Malaria in Brazil: an overview. Malar J 9:115. doi: 10.1186/1475-2875-9-115 PubMedCentralPubMedCrossRefGoogle Scholar
  44. Orostegui-Pinilla D, Rodriguez-Morales AJ (2011) Neonatal Plasmodium vivax malaria. Trop Biomed 28(2):339–342PubMedGoogle Scholar
  45. Pedro RS, Guaraldo L, Campos DP, Costa AP, Daniel-Ribeiro CT, Brasil P (2012) Plasmodium vivax malaria relapses at a travel medicine centre in Rio de Janeiro, a non-endemic area in Brazil. Malar J 11:245. doi: 10.1186/1475-2875-11-245 PubMedCentralPubMedCrossRefGoogle Scholar
  46. Picot S, Bienvenu AL (2009) Plasmodium vivax infection: not so benign. Med Sci 25(6–7):622–626. doi: 10.1051/medsci/2009256-7622 Google Scholar
  47. Pineros-Jimenez JG, Arboleda M, Jaramillo JC, Blair S (2008) Report of five cases of severe neonatal Plasmodium vivax malaria in Uraba, Colombia. Biomedica : revista del Instituto Nacional de Salud 28(4):471–479CrossRefGoogle Scholar
  48. Poespoprodjo JR, Fobia W, Kenangalem E, Hasanuddin A, Sugiarto P, Tjitra E, Anstey NM, Price RN (2011) Highly effective therapy for maternal malaria associated with a lower risk of vertical transmission. J Infect Dis 204(10):1613–1619. doi: 10.1093/infdis/jir558 PubMedCentralPubMedCrossRefGoogle Scholar
  49. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM (2007) Vivax malaria: neglected and not benign. Am J Trop Med Hyg 77(6 Suppl):79–87PubMedCentralPubMedGoogle Scholar
  50. Quintero JP, Siqueira AM, Tobon A, Blair S, Moreno A, Arevalo-Herrera M, Lacerda MV, Valencia SH (2011) Malaria-related anaemia: a Latin American perspective. Mem Inst Oswaldo Cruz 106(Suppl 1):91–104PubMedCrossRefGoogle Scholar
  51. Raccurt CP, Ciceron M, Dossil R, Boncy J (2012) Prevalence of Plasmodium falciparum during the rainy season (June-December) in the southeast district of Haiti. Med Sante Trop 22(4):435–439. doi: 10.1684/mst.2013.0124 PubMedGoogle Scholar
  52. Raposo CC, Santos JB, Santos GM, Goncalves Eda G, Silva AR (2013) Plasmodium vivax malaria: related factors to severity in the State of Maranhão, Brazil. Rev Soc Bras Med Trop 46(1):67–72PubMedCrossRefGoogle Scholar
  53. Rodriguez-Morales AJ (2008) Malaria: an eradicable threat? J Infect Dev Ctries 2(1):1–2PubMedCrossRefGoogle Scholar
  54. Rodriguez-Morales AJ, Benitez JA, Franco-Paredes C (2006a) Acute respiratory distress syndrome in Plasmodium vivax malaria in traveler returning from Venezuela. J Travel Med 13(5):325–326. doi: 10.1111/j.1708-8305.2006.0064_1.x, Author reply 326PubMedCrossRefGoogle Scholar
  55. Rodriguez-Morales AJ, Delgado L, Martinez N, Franco-Paredes C (2006b) Impact of imported malaria on the burden of disease in northeastern Venezuela. J Travel Med 13(1):15–20. doi: 10.1111/j.1708-8305.2006.00006.x PubMedCrossRefGoogle Scholar
  56. Rodriguez-Morales AJ, Sanchez E, Vargas M, Piccolo C, Colina R, Arria M (2006c) Anemia and thrombocytopenia in children with Plasmodium vivax malaria. J Trop Pediatr 52(1):49–51. doi: 10.1093/tropej/fmi069 PubMedCrossRefGoogle Scholar
  57. Rodriguez-Morales AJ, Sanchez E, Vargas M, Piccolo C, Colina R, Arria M, Franco-Paredes C (2006d) Is anemia in Plasmodium vivax malaria more frequent and severe than in Plasmodium falciparum? Am J Med 119(11):e9–e10. doi: 10.1016/j.amjmed.2005.08.014 PubMedCrossRefGoogle Scholar
  58. Rodriguez-Morales AJ, Sanchez E, Vargas M, Piccolo C, Colina R, Arria M, Franco-Paredes C (2006e) Pregnancy outcomes associated with Plasmodium vivax malaria in northeastern Venezuela. Am J Trop Med Hyg 74(5):755–757PubMedGoogle Scholar
  59. Rodriguez-Morales AJ, Arria M, Sanchez E, Vargas M, Piccolo C, Colina R, Franco-Paredes C (2007a) Outcomes of imported malaria during pregnancy within Venezuelan states: implications for travel advice. J Travel Med 14(1):67–71. doi: 10.1111/j.1708-8305.2006.00099.x PubMedCrossRefGoogle Scholar
  60. Rodriguez-Morales AJ, Sanchez E, Arria M, Vargas M, Piccolo C, Colina R, Franco-Paredes C (2007b) Haemoglobin and haematocrit: the threefold conversion is also non valid for assessing anaemia in Plasmodium vivax malaria-endemic settings. Malar J 6:166. doi: 10.1186/1475-2875-6-166 PubMedCentralPubMedCrossRefGoogle Scholar
  61. Rodriguez-Morales AJ, Benitez JA, Arria M (2008) Malaria mortality in Venezuela: focus on deaths due to Plasmodium vivax in children. J Trop Pediatr 54(2):94–101. doi: 10.1093/tropej/fmm074 PubMedCrossRefGoogle Scholar
  62. Rodriguez-Morales AJ, Ferrer MV, Barrera MA, Pacheco M, Daza V, Franco-Paredes C (2009) Imported cases of malaria admitted to two hospitals of Margarita Island, Venezuela, 1998–2005. Travel Med Infect Dis 7(1):44–48. doi: 10.1016/j.tmaid.2008.09.006 PubMedCrossRefGoogle Scholar
  63. Rodriguez-Morales AJ, Herrera-Martinez AD, Herrera-Martinez Y (2010) Imported cases of malaria admitted to a hospital in Western Venezuela, 1998–2009. Travel Med Infect Dis 8(4):269–271. doi: 10.1016/j.tmaid.2010.07.003 PubMedCrossRefGoogle Scholar
  64. Rodríguez-Morales AJ, Jimenez-Canizales CE, Herrera AC, Medina A, Martínez JW (2012) Patrones de comportamiento de la malaria en el departamento de Risaralda, Colombia, 2007–2009. Rev Med Risaralda 18(1):7Google Scholar
  65. Rodríguez-Morales AJ, Giselle-Badillo A, Manrique-Castaño S, Yepes MC (2014a) Anemia and thrombocytopenia in Plasmodium vivax malaria is not unusual in patients from endemic and nonendemic settings. Travel Med Infect Dis 12(5):549–550. doi: 10.1016/j.tmaid.2014.07.006 PubMedCrossRefGoogle Scholar
  66. Rodríguez-Morales AJ, Paniz-Mondolfi AE (2014b) Venezuela’s failure in malaria control. Lancet 384(9944):663–664PubMedCrossRefGoogle Scholar
  67. Rodríguez-Morales AJ, Paniz-Mondolfi AE (2015) Venezuela: far from the path to dengue and chikungunya control. J Clin Virol 66:60–61. doi: 10.1016/j.jcv.2015.02.020
  68. Rodulfo H, de Donato M, Quijada I, Pena A (2007) High prevalence of malaria infection in Amazonas State, Venezuela. Rev Inst Med Trop Sao Paulo 49(2):79–85PubMedCrossRefGoogle Scholar
  69. Rosas-Aguirre A, Gamboa D, Rodriguez H, Llanos-Zavalaga F, Aguirre K, Llanos-Cuentas A (2010) Use of standardized blood smear slide sets for competency assessment in the malaria microscopic diagnosis in the Peruvian Amazon. Rev Peru Med Exp Salud Publica 27(4):540–547PubMedCrossRefGoogle Scholar
  70. Rubio-Palis Y, Bevilacqua M, Medina DA, Moreno JE, Cardenas L, Sanchez V, Estrada Y, Anaya W, Martinez A (2013) Malaria entomological risk factors in relation to land cover in the Lower Caura River Basin, Venezuela. Mem Inst Oswaldo Cruz 108(2):220–228PubMedCentralPubMedCrossRefGoogle Scholar
  71. Ruebush TK 2nd, Zegarra J, Cairo J, Andersen EM, Green M, Pillai DR, Marquino W, Huilca M, Arevalo E, Garcia C, Solary L, Kain KC (2003) Chloroquine-resistant Plasmodium vivax malaria in Peru. Am J Trop Med Hyg 69(5):548–552PubMedGoogle Scholar
  72. Singh H, Parakh A, Basu S, Rath B (2011) Plasmodium vivax malaria: is it actually benign? J Infect Public Health 4(2):91–95. doi: 10.1016/j.jiph.2011.03.002 PubMedCrossRefGoogle Scholar
  73. Siqueira AM, Alexandre MA, Mourao MP, Santos VS, Nagahashi-Marie SK, Alecrim MG, Lacerda MV (2010) Severe rhabdomyolysis caused by Plasmodium vivax malaria in the Brazilian Amazon. Am J Trop Med Hyg 83(2):271–273. doi:10.4269/ajtmh. 2010.10-0027PubMedCentralPubMedCrossRefGoogle Scholar
  74. Tan LK, Yacoub S, Scott S, Bhagani S, Jacobs M (2008) Acute lung injury and other serious complications of Plasmodium vivax malaria. Lancet Infect Dis 8(7):449–454. doi: 10.1016/S1473-3099(08)70153-1 PubMedCrossRefGoogle Scholar
  75. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN (2008) Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 5(6):e128. doi: 10.1371/journal.pmed.0050128 PubMedCentralPubMedCrossRefGoogle Scholar
  76. United Nations Development Programme (2012a) Human development indicators. Guyana. http://hdr.undp.org/en/countries/profiles/GUY
  77. United Nations Development Programme (2012b) Human development indicators. Venezuela. http://hdr.undp.org/en/countries/profiles/VEN
  78. Vinetz JM (2006) Emerging chloroquine-resistant Plasmodium vivax (Benign Tertian) malaria: the need for alternative drug treatment. Clin Infect Dis 42(8):1073–1074. doi: 10.1086/501353 PubMedCrossRefGoogle Scholar
  79. White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM (2014) Malaria. Lancet 383(9918):723–735. doi: 10.1016/S0140-6736(13)60024-0 PubMedCrossRefGoogle Scholar
  80. Wilson ME, Freedman DO (2007) Etiology of travel-related fever. Curr Opin Infect Dis 20(5):449–453. doi: 10.1097/QCO.0b013e3282a95e27 PubMedGoogle Scholar
  81. World Health Organization (2013) World malaria report. World Health Organization, GenevaGoogle Scholar
  82. World Health World Health (2000) Severe falciparum malaria. Trans R Soc Trop Med Hyg 94(Suppl 1):S1–S90CrossRefGoogle Scholar
  83. WHO (2014) Severe malaria. Trop Med Int Health 19(Suppl 1):7–131Google Scholar
  84. Zerpa N, Pabon R, Wide A, Gavidia M, Medina M, Caceres JL, Capaldo J, Baker M, Noya O (2008) Evaluation of the OptiMAL test for diagnosis of malaria in Venezuela. Invest Clin 49(1):93–101PubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2015

Authors and Affiliations

  • Alfonso J. Rodriguez-Morales
    • 1
    Email author
  • Adrián Bolívar-Mejía
    • 2
  • Camila Alarcón-Olave
    • 3
  • Lauren S. Calvo-Betancourt
    • 4
  1. 1.Universidad Tecnológica de PereiraPereiraColombia
  2. 2.Clínica FOSCAL InternacionalFloridablancaColombia
  3. 3.Universidad Autónoma de BucaramangaBucaramangaColombia
  4. 4.Fundación Cardiovascular de ColombiaFloridablancaColombia

Personalised recommendations